Dr. Been analyzes molnupiravir Phase II/III trial versus ivermectin and demonstrates that if molnupiravir obtains a C19 EUA, ivermectin has also long been entitled to a C19 EUA

Drbeen Medical Lectures

Molnupiravir, Bamlanivimab, Remdesivir, and Ivermectin Studies

If authorized/approved, Merck’s Molnupiravir is an excellent new addition to the toolset for the physicians to manage COVID-19. I believe this will be the last straw for the SARS-COV-2 to become an endemic from a pandemic. Let’s review the timeline, trial, order placement, and possibly imminent EUA as compared to other drugs like Bamlanivimab, etc.

Disclaimer: This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only. Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional. #drbeen #koolbeens #COVID
Translate »